Well, we, of course, already undertake a range of mobile cancer treatment services, and you will be very well aware of our ambition to undertake more care within the community—that shift from secondary to primary care. It’s an important part of what we wish to do. That would certainly be the case within cancer services as well. We have had well-established programmes, working with Macmillan Cancer Support, for example, on understanding primary care oncology services. We are working with our clinicians to improve what they do and to make sure that care is provided in the most appropriate setting. I will make no apology for not accepting or following Tory proposals for a Welsh cancer drugs fund. We do not believe that that is the right thing to do. It’s not just that: the Public Accounts Committee of the House of Commons said there was no evidence of improved outcomes from the English fund, and Sir Bruce Keogh, whom the Tories are often fond of quoting in this Chamber, has described the cancer drugs fund as not a smart and sustainable use of money. He recognised that more of the budget there is being spent on less effective medication. That is a poor model for us to follow, and I’m proud of what we are already doing and what we are committed to doing with the new treatment fund.